SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-152946
Filing Date
2023-05-24
Accepted
2023-05-24 16:14:00
Documents
19
Period of Report
2023-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d452618d8k.htm   iXBRL 8-K 31476
2 EX-1.1 d452618dex11.htm EX-1.1 171082
3 EX-5.1 d452618dex51.htm EX-5.1 14247
4 EX-99.1 d452618dex991.htm EX-99.1 8667
5 EX-99.2 d452618dex992.htm EX-99.2 8712
9 GRAPHIC g452618dsp34.jpg GRAPHIC 4009
10 GRAPHIC g452618dsp35.jpg GRAPHIC 2197
11 GRAPHIC g452618g0524101709550.jpg GRAPHIC 3322
  Complete submission text file 0001193125-23-152946.txt   435338

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA phat-20230523.xsd EX-101.SCH 2869
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20230523_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20230523_pre.xml EX-101.PRE 11720
13 EXTRACTED XBRL INSTANCE DOCUMENT d452618d8k_htm.xml XML 3476
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 23954282
SIC: 2834 Pharmaceutical Preparations